Ashish Bhimani, MD
Clinical Cardiac Electrophysiology · Atlanta, GANPI 1770600181
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (37.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Abbott at 47.4% of the total. Reporting peaked in 2019 at $24,326 and has fallen 62.5% since, to $9,119 in 2025.
Across 389 payments — averaging $131.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$24K
- Biotronik Inc.$14K
- Medtronic$6K
- Biosense Webster, Inc.$2K
- Boston Scientific$1K
- Cvrx, Inc.$893
- plus $3K from 25 others
What the payments were for
- Consulting fees$19,16637%
- Speaking & faculty fees$6,00012%
- Travel & lodging$14,24828%
- Food & beverage$11,74023%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 91 | $24,224 |
| Biotronik Inc. | 13 | $14,347 |
| Medtronic(2 entities) | 32 | $5,956 |
| Biosense Webster, Inc. | 71 | $1,828 |
| Boston Scientific | 32 | $1,386 |
| Cvrx, Inc. | 20 | $893 |
| Johnson & Johnson | 41 | $527 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $250 |
| Pfizer | 11 | $219 |
| E.r. Squibb & Sons, L.L.C. | 12 | $211 |
| Acutus Medical, Inc. | 1 | $209 |
| Cardiva Medical, Inc. | 9 | $167 |
| Amgen | 6 | $94 |
| Novartis | 5 | $92 |
| Atricure, Inc. | 4 | $90 |
| Sanofi-aventis U.S. LLC | 4 | $89 |
| Boehringer Ingelheim | 3 | $77 |
| Irhythm Technologies, Inc. | 4 | $71 |
| Edwards Lifesciences | 2 | $54 |
| Bayer | 2 | $48 |
| Vital Connect, Inc | 2 | $45 |
| EBR Systems, Inc. | 1 | $44 |
| Convatec Inc. | 2 | $36 |
| Baxter Healthcare | 2 | $35 |
| Philips North America LLC | 1 | $31 |
| Itamar Medical Inc | 1 | $26 |
| Innovation Technologies Inc | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Elutia, Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tendril Pacing Lead$13,323
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$6,768
- AVEIR$1,441
- Barostim Neo System$503
- AFFERA MAPPING SYSTEM$477
- Micra$434
- Quadra Assura CRT Defibrillator$424
- Carto 3$345
- QDOT MICRO Catheter$330
- WATCHMAN Access System$232
- PulseSelect$184
- AVVIGO Guidance System$174
- ASSURITY$161
- QUADRA ASSURA$146
- FARAWAVE$145
- Accent Pacemaker$131
- FINELINE II Sterox$125
- Assurity Pacemaker$122
- QDOT MICRO$121
- GENERAL - THERAPIES$118
How this compares
$51,154 in reported general payments places this provider in the 75th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
See all clinical cardiac electrophysiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 408 | $465,586 |
| XareltoRivaroxaban | 95 | $116,688 |
| MultaqDronedarone Hcl | 12 | $27,905 |
| Dofetilide | 93 | $13,849 |
| Flecainide Acetate | 154 | $6,110 |
| Metoprolol Succinate | 251 | $3,496 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 78 | $2,876 |
| Metoprolol Tartrate | 227 | $1,371 |
| Amiodarone Hcl | 74 | $1,349 |
| Carvedilol | 81 | $996 |
| Digoxin | 30 | $566 |
| SotalolSotalol Hcl | 39 | $495 |
| Amlodipine Besylate | 32 | $147 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $130 |
| Lisinopril | 22 | $102 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $219 | $465,586408 claims |
| Johnson & JohnsonXarelto | $527 | $116,68895 claims |
| Sanofi-aventis U.S. LLCMultaq | $89 | $27,90512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
Other clinical cardiac electrophysiology in Atlanta
- David DelurgioAtlanta$695K
- Thomas DeeringAtlanta$237K
- Michael LloydAtlanta$221K
- Mikhael El-ChamiAtlanta$172K
- Sandeep GoyalAtlanta$153K
- Bruce StamblerAtlanta$91K
- Stacy WestermanAtlanta$60K
- Aaron RichardsonAtlanta$51K
- Devinder DhindsaAtlanta$47K
- Ahmadreza KarimianpourAtlanta$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.